Effect of iron supplementation in patients with heart failure and iron deficiency: A systematic review and meta-analysis

Effect of iron supplementation in patients with heart failure and iron deficiency: A systematic review and meta-analysis

Background: The effectiveness of oral and intravenous iron supplementation in reducing the risk of mortality and hospitalizations in HF patients with iron deficiency is not well-established. Methods: A thorough literature search was conducted across 2 electronic databases (Medline and Cochrane Centr...

Full description

Bibliographic Details
Main Authors:	Naser Yamani, Aymen Ahmed, Priyanka Gosain, Kaneez Fatima, Ali Tariq Shaikh, Humera Qamar, Izza Shahid, Muhammad Sameer Arshad, Talal Almas, Vincent Figueredo
Format:	Article
Language:	English
Published:	Elsevier 2021-10-01
Series:	International Journal of Cardiology: Heart & Vasculature
Subjects:	Oral Intravenous Iron sucrose Ferric carboxymaltose Heart failure Iron deficient
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352906721001597

Similar Items

Parenteral Iron Therapy for Pediatric Patients
by: Elpis Mantadakis, et al.
Published: (2024-01-01)

A comparative study of ferric carboxymaltose and iron sucrose as a parenteral iron treatment in iron deficiency anemia during pregnancy in a tertiary care hospital
by: Sandip Kumar Ghosh, et al.
Published: (2024-04-01)

Differential Pharmacokinetics of Liver Tropism for Iron Sucrose, Ferric Carboxymaltose, and Iron Isomaltoside: A Clue to Their Safety for Dialysis Patients
by: Guy Rostoker, et al.
Published: (2022-07-01)

Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials
by: Amreen Naqash, et al.
Published: (2018-01-01)

Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients
by: Jesse M. G. Hofman, et al.
Published: (2018-09-01)

Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women
by: Jae-Yoon Shim, et al.
Published: (2018-08-01)

Ferric carboxymaltose solution versus iron sucrose complex in treating Iron-deficiency anemia patients with heavy uterine bleeding: A cost-efficacy study from a tertiary care hospital in the Kingdom of Saudi Arabia
by: Ayman Hejazi, et al.
Published: (2021-01-01)

Clinical and biochemical features of some intravenous iron complexes
by: S. Yu. Abashin, et al.
Published: (2014-07-01)

Clinical and biochemical features of some intravenous iron complexes
by: S. Yu. Abashin, et al.
Published: (2014-07-01)

Iron substitution in the treatment of chronic heart failure
by: Christine Gstrein, et al.
Published: (2017-06-01)

Efficacy and Safety of Intravenous Ferric Carboxymaltose Treatment of Iron Deficiency Anaemia in Patients with Corpus Atrophic Gastritis: A Retrospective Study
by: Ludovica Dottori, et al.
Published: (2023-09-01)

Effect of parenteral iron treatment on platelet counts in women who do not have concomitant diseases
by: Recep Alanli, et al.
Published: (2022-01-01)

Does Repeated Dosing of Intravenous Ferric Carboxymaltose Alleviate Symptoms of Restless Legs Syndrome?
by: Hea Ree Park, et al.
Published: (2022-03-01)

To evaluate the efficacy and safety of intravenous ferrous carboxymaltose compared with Iron sucrose in treating iron deficiency anemia in postpartum period
by: Akriti Gupta, et al.
Published: (2022-12-01)

Patient-Reported Outcomes After Ferric Carboxymaltose Treatment for Iron Deficiency Anemia: A Prospective Observational Study
by: Kwong WJ, et al.
Published: (2023-08-01)

Iron deficiency anemia with menorrhagia: Ferric carboxymaltose a safer alternative to blood transfusion
by: Vineet Mishra, et al.
Published: (2018-01-01)

Effects of intravenous iron monotherapy for patients with iron deficient anemia undergoing total knee arthroplasty
by: Kyun-Ho Shin, et al.
Published: (2020-08-01)

Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia
by: Burak Yasin Aktaş, et al.
Published: (2023-11-01)

Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease
by: Patricia Garcia-Ortega, et al.
Published: (2022-10-01)

Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐term study
by: Tilmann Kramer, et al.
Published: (2021-12-01)

IRON-DEFICIENCY ANEMIA IN PREGNANCY: PECULIARITIES OF THERAPY
by: M. A. Vinogradova
Published: (2018-01-01)

Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: a narrative review
by: Xenophon Kassianides, et al.
Published: (2021-01-01)

Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial‐IRON Trial
by: Julio Núñez, et al.
Published: (2020-02-01)

Efficacy and safety of intravenous ferric carboxymaltose in iron deficiency anemia; Real-life data from Turkey, a single center experience
by: Ali Eser, et al.
Published: (2021-06-01)

Effect of intravenous iron replacement therapy on exercise capacity in iron deficient anemic patients after cardiac surgery
by: Cinzia Nugara, et al.
Published: (2020-03-01)

A Randomized controlled trial of the Effect of intraVenous iron on Anaemia in Malawian Pregnant women (REVAMP): Statistical analysis plan [version 2; peer review: 2 approved]
by: Rebecca Harding, et al.
Published: (2022-04-01)

A Randomized controlled trial of the Effect of intraVenous iron on Anaemia in Malawian Pregnant women (REVAMP): Statistical analysis plan [version 1; peer review: 2 approved]
by: Rebecca Harding, et al.
Published: (2021-12-01)

Problem of iron-deficiency anemia in patients with cancers: practice in using iron-containing drugs
by: A V Snegovoy
Published: (2013-06-01)

Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How?
by: Andrew Sindone, et al.
Published: (2022-05-01)

Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose
by: Wendy Fang, et al.
Published: (2019-10-01)

Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose—the randomized controlled HOMe aFers study
by: I. E. Emrich, et al.
Published: (2020-07-01)

Comparison of short-term efficacy of iron sucrose with those of ferric chloride in hemodialysis patients: An open-label study
by: Po-Jen Hsiao, et al.
Published: (2016-01-01)

A rare case of parental iron-induced persistent hypophosphatemia
by: Abigayle Sullivan, et al.
Published: (2020-03-01)

Iron replacement therapy in heart failure: a literature review
by: Hassan Ismahel, et al.
Published: (2021-09-01)

Incidence of Hypophosphatemia after Ferric Carboxymaltose Treatment: Single Center Experience
by: Esra TERZİ DEMİRSOY
Published: (2021-08-01)

Short-term treatment of iron deficiency anemia after cardiac surgery
by: Elio VENTURINI, et al.
Published: (2022-06-01)

Comparing the efficacy between ferrous carboxymaltose and iron sucrose therapy in iron deficiency anemia during pregnancy in Obstetrics and Gynecology ward at tertiary care hospital, Jaipur
by: Kamal Saini, et al.
Published: (2020-01-01)

Effect of Preoperative Administration of Intravenous Ferric Carboxymaltose in Patients with Iron Deficiency Anemia after Off-Pump Coronary Artery Bypass Grafting: A Randomized Controlled Trial
by: Hyo-Hyun Kim, et al.
Published: (2023-02-01)

Iron deficiency in heart failure
by: Goran Loncar, et al.
Published: (2021-08-01)

Effect of IV ferric carboxy maltose for moderate/severe anemia: a systematic review and meta-analysis
by: Mahalaqua Nazli Khatib, et al.
Published: (2024-02-01)